Background
Methods
Ethical clearance
Study area
Study group/study period
Sample collection
Parasitological examination
Anti MSP/CSP antibody card assay
Nested polymerase chain reaction (PCR)
Analysis of the amplified gene products
Purification and quantification of amplified DNA
Sequencing/genotyping of the purified parasite DNA and DARC gene promoter DNA fragment
Bioinformatics (in silico) analyses of the sequenced parasite DNA
Duffy blood group determination
Analysis of the amplified gene products
Purification and quantification of the amplified 224 bp DARC gene promoter DNA fragment
Bioinformatics (in silico) analyses of the sequenced DARC gene promoter fragment
Wet lab StyI restriction digestion of the amplified DARC gene promoter fragment
In silico StyI restriction digestion of the DARC promoter sequences
Statistical analyses
Results
Detection of Plasmodium vivax and Plasmodium falciparum infection by Giemsa
Detection of anti-parasite antibodies to P. vivax and P. falciparum in asymptomatic subjects
P. falciparum
|
P. vivax
|
P. falciparum + P. vivax
|
---|---|---|
Percent fraction of total samples shown in parenthesis* | Percent fraction of total samples shown in parenthesis* | Percent fraction of total samples shown in parenthesis* |
180 (66.9) | 3 (1.1) | 11 (4.1) |
Detection of malaria species in asymptomatic subjects by nested PCR
2008 % (n/Total n) | |
---|---|
Pf
| 24.5 (66/269) |
Pv
| 3.3 (9/269) |
Pm
| 1.5 (4/269) |
Po
| 0.0 (0/269) |
Pf + Pv
| 1.1 (3/269) |
Pf + Pm
| 1.5 (4/269) |
Pf + Pv + Pm
| 0.4 (1/269) |